LMR Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

LMR Partners’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-31,000	Closed	-$3.25M	–	591
2018 Q1	$3.25M	Hold	31,000	–	–	0.33%	51
2017 Q4	$3.25M	Buy	+31,000	New	+$3.41M	0.33%	51
2017 Q3	–	Sell	-4,185	Closed	-$469K	–	582
2017 Q2	$469K	Buy	+4,185	New	+$473K	0.03%	417
2016 Q2	–	Sell	-8,620	Closed	-$1.24M	–	607
2016 Q1	$1.24M	Buy	+8,620	New	+$1.22M	0.13%	146

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

LMR Partners's TARO Position: Q2 2018 in Review

LMR Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2018, closing a stake of 31,000 shares — an estimated $3.25M sold.

LMR Partners first reported a position in TARO in Q1 2016 and held it in 4 quarters. The position peaked at $3.25M in Q1 2018. 109 funds tracked by Wall St. Rank hold TARO as of Q2 2018.

LMR Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2018 after selling out during the quarter.
LMR Partners sold 31,000 Taro Pharmaceutical Industries Ltd. shares in Q2 2018, an estimated $3.25M.
LMR Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 4 quarters.
LMR Partners's Taro Pharmaceutical Industries Ltd. position peaked at $3.25M in Q1 2018.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2018.

Based on LMR Partners's 13F filing for Q2 2018, filed 3 Aug 2018.